Pfizer set to request emergency approval of COVID-19 vaccine for children younger than 5
U.S. regulators are planning to review and authorize Pfizer and BioNTech's COVID-19 vaccine for children younger than 5 before data on a third -- and potentially necessary -- shot is available.